L322-0251 Screening compound: N-[6-(benzenesulfonyl)-1,3-diethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-4-methylbenzamide

L322-0251 Screening compound: N-[6-(benzenesulfonyl)-1,3-diethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-4-methylbenzamide
L322-0251 Screening compound: N-[6-(benzenesulfonyl)-1,3-diethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-4-methylbenzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L322-0251
N-[6-(benzenesulfonyl)-1,3-diethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-4-methylbenzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L322-0251

Molecular Formula

C25H25N3O4S (C25 H25 N3 O4 S)

Compound Name

N-[6-(benzenesulfonyl)-1,3-diethyl-2-oxo-2,3-dihydro-1H-1,3-benzodiazol-5-yl]-4-methylbenzamide

IUPAC name

N-[6-(benzenesulfonyl)-13-diethyl-2-oxo-23-dihydro-1H-13-benzodiazol-5-yl]-4-methylbenzamide

SMILES

CCN(c(c(N1CC)c2)cc(NC(c3ccc(C)cc3)=O)c2S(c2ccccc2)(=O)=O)C1=O

InChI

InChI=1S/C25H25N3O4S/c1-4-27-21-15-20(26-24(29)18-13-11-17(3)12-14-18)23(16-22(21)28(5-2)25(27)30)33(31,32)19-9-7-6-8-10-19/h6-16H,4-5H2,1-3H3,(H,26,29)

InChI Key

ZKIUDWHRBBKQJO-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27244880

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

463.56

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.922

Distribution Coefficient, logD

4.907

Water Solubility, LogSw

-4.52

Polar Surface Area

69.735

Acid Dissociation Constant (pKa)

8.85

Base Dissociation Constant (pKb)

-2.78

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.00

L322-0251 in Drug Discovery

Included in Screening Libraries

Hsp90-Targeted Library (11355 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system

References: we are preparing a list of scientific research reports with L322-0251 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L322-0251?
Check Price and Availability of L322-0251, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L322-0251 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L322-0251
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L322-0251
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L322-0251 available by request